Journal issue overview 39/2020 Diabetes and obesity

3

Editorial

7

Comparison of the most recent guidelines for hyperglycemia management in patients with type 2 diabetes mellitus

Zbynek Schroner, Vladimír Uličiansky

12

Concentrations of fT3 in child patients with obesity

Dana Černochová, Jana Kohanová, Jana Poddaná, Eva Mendelová, Jarmila Vojtková, Miriam Čiljaková

16

Non-alcoholic fatty liver disease from the point of view of diabetologist

Vladimír Uličiansky

22

Diabetes mellitus and liver diseases

Rid Dravecká

28

The benefit of insulin glargine 300 U/ml for specific groups of patients in the context of available data

Peter Novodvorský

35

Management of antidiabetic treatment in an elderly fragile patient with diabetes mellitus

Zbynek Schroner, Vladimír Uličiansky

42

Peroral antidiabetics and thyroid diseases

Štefan Sotak

47

COVID-19: the topic of the day

Viera Doničová

51

Comparison of cardiovascular studies with GLP-1 receptor agonists and their implication for clinical practice

Zbynek Schroner

57

Therapy with SGLT2 inhibitors: case reports

Andrea Mokošová, O. Ga Rybárová, Zbynek Schroner

61

Treatment with the new modified insulin glargine (Semglee) in a patient with type 1 diabetes mellitus: case report

Alexandra Brečková

63

A positive effect of intensification of the treatment with biosimilar insulin glargine on metabolic compensation: case report

Lucia Kizeková

65

Treatment with biosimilar insulin glargine in clinical practice: case report

Adriana Philippiová

66

Edukácia v diabetologickom edukačnom centre v Martine

Andrea Bukovská

68

Diabetology EDUCATION FORUM

Radovan Plášil

Diabetes and obesity - Issue 39/2020

Editorial

Guidelines

Reviews

Clinical studies

Case studies

News

News

Diabetes and obesity